Molteni is an italian private-owned pharmaceutical company, founded in 1892 in Florence.
Molteni is active in the development, manufacturing and marketing of finished pharmaceutical products in different strenghts and formulations.
Molteni’s mainly deal with controlled drug substances of finished products in pain and addiction treatment.
The company is growing at international level with agreements with qualified local partner/distributors, out-licensing agreements and thanks to a direct presence in Poland since 1994.
In 2018 Molteni finalized an agreement regarding an innovative implant product (SIXMO) containing buprenorphine for long treatment of heroin addiction. Molteni acquired rights of for EU and some other countries outside EU (among them Russia and Iran).
SIXMO was registered at EMA (European level), last June 2019.

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Anesthetics services

Molteni Farmaceutici

Request Info

Drug addiction services

Molteni Farmaceutici

Request Info

Morphine

Molteni Farmaceutici

Request Info

Nasal spray for pain

Molteni Farmaceutici

Request Info